Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors. The company develops MB-117 and MB-217, a gene therapy program for X-linked severe combined immunodeficiency, a rare genetic immune system condition in which affected patients do not live beyond infancy without treatment. The company also develops MB-106 CAR T cell program for B cell non-hodgkin lymphoma and chronic lymphocytic leukemia; MB-101 CAR T cell program for glioblastoma; MB-108, a next-generation oncolytic herpes simplex virus. It has license agreements with Nationwide Children's Hospital, CSL Behring; Mayo Clinic; Leiden University Medical Centre; SIRION Biotech GmbH. The company was incorporated in 2015 and is headquartered in Worcester, Massachusetts. Avenue Mustang Bio, Inc. is a subsidiary of Fortress Biotech, Inc. more
Time Frame | MBIO | Sector | S&P500 |
---|---|---|---|
1-Week Return | 17.6% | 0.49% | -1.93% |
1-Month Return | 37.96% | -3.1% | -3.69% |
3-Month Return | 16.64% | -8.59% | 0.82% |
6-Month Return | -41.99% | -4.57% | 3.51% |
1-Year Return | -80.41% | -0.94% | 21.91% |
3-Year Return | -98.92% | 2.88% | 24.73% |
5-Year Return | -99.59% | 35.84% | 78.4% |
10-Year Return | -99.83% | 98.8% | 187.28% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Cost of Revenue | 1.37M | 1.78M | 2.31M | 3.03M | 2.23M | [{"date":"2019-12-31","value":45.13,"profit":true},{"date":"2020-12-31","value":58.89,"profit":true},{"date":"2021-12-31","value":76.08,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":73.41,"profit":true}] |
Gross Profit | (1.37M) | (1.78M) | (2.31M) | (3.03M) | (2.23M) | [{"date":"2019-12-31","value":-136800000,"profit":false},{"date":"2020-12-31","value":-178500000,"profit":false},{"date":"2021-12-31","value":-230600000,"profit":false},{"date":"2022-12-31","value":-303100000,"profit":false},{"date":"2023-12-31","value":-222500000,"profit":false}] |
Gross Margin | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Operating Expenses | 45.88M | 56.81M | 66.72M | 74.86M | 48.50M | [{"date":"2019-12-31","value":61.3,"profit":true},{"date":"2020-12-31","value":75.89,"profit":true},{"date":"2021-12-31","value":89.14,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":64.79,"profit":true}] |
Operating Income | (45.88M) | (56.81M) | (66.72M) | (76.16M) | (50.73M) | [{"date":"2019-12-31","value":-4588500000,"profit":false},{"date":"2020-12-31","value":-5680600000,"profit":false},{"date":"2021-12-31","value":-6672300000,"profit":false},{"date":"2022-12-31","value":-7615900000,"profit":false},{"date":"2023-12-31","value":-5072600000,"profit":false}] |
Total Non-Operating Income/Expense | (1.01M) | (6.42M) | 706.00K | (4.04M) | (5.10M) | [{"date":"2019-12-31","value":-142.78,"profit":false},{"date":"2020-12-31","value":-909.07,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-571.67,"profit":false},{"date":"2023-12-31","value":-722.1,"profit":false}] |
Pre-Tax Income | (46.39M) | (60.02M) | (66.37M) | (77.53M) | (51.60M) | [{"date":"2019-12-31","value":-4638900000,"profit":false},{"date":"2020-12-31","value":-6001500000,"profit":false},{"date":"2021-12-31","value":-6637000000,"profit":false},{"date":"2022-12-31","value":-7752500000,"profit":false},{"date":"2023-12-31","value":-5160200000,"profit":false}] |
Income Taxes | 1.77M | 2.13M | (2.29M) | 1.37M | - | [{"date":"2019-12-31","value":82.88,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-107.46,"profit":false},{"date":"2022-12-31","value":64.07,"profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Income After Taxes | (48.16M) | (62.15M) | (64.08M) | (78.89M) | - | [{"date":"2019-12-31","value":-4815600000,"profit":false},{"date":"2020-12-31","value":-6214700000,"profit":false},{"date":"2021-12-31","value":-6407900000,"profit":false},{"date":"2022-12-31","value":-7889100000,"profit":false},{"date":"2023-12-31","value":"-","profit":true}] |
Income From Continuous Operations | (46.39M) | (60.02M) | (66.37M) | (77.53M) | (62.62M) | [{"date":"2019-12-31","value":-4638900000,"profit":false},{"date":"2020-12-31","value":-6001500000,"profit":false},{"date":"2021-12-31","value":-6637000000,"profit":false},{"date":"2022-12-31","value":-7752500000,"profit":false},{"date":"2023-12-31","value":-6262000000,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (48.16M) | (62.15M) | (64.08M) | (78.89M) | (51.60M) | [{"date":"2019-12-31","value":-4815600000,"profit":false},{"date":"2020-12-31","value":-6214700000,"profit":false},{"date":"2021-12-31","value":-6407900000,"profit":false},{"date":"2022-12-31","value":-7889100000,"profit":false},{"date":"2023-12-31","value":-5160200000,"profit":false}] |
EPS (Diluted) | (1.30) | (1.15) | (0.76) | (3.27) | (6.32) | [{"date":"2019-12-31","value":-130,"profit":false},{"date":"2020-12-31","value":-115,"profit":false},{"date":"2021-12-31","value":-76,"profit":false},{"date":"2022-12-31","value":-327,"profit":false},{"date":"2023-12-31","value":-632,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
MBIO | |
---|---|
Cash Ratio | 0.23 |
Current Ratio | 0.40 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
MBIO | |
---|---|
ROA (LTM) | -96.52% |
ROE (LTM) | -1191.31% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
MBIO | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 2.20 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | -1.20 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
MBIO | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 0.00 |
P/B | 31.75 |
Price/FCF | NM |
EV/R | 0.00 |
EV/Ebitda | NM |
Mustang Bio Inc (MBIO) share price today is $0.224
Yes, Indians can buy shares of Mustang Bio Inc (MBIO) on Vested. To buy Mustang Bio Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in MBIO stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Mustang Bio Inc (MBIO) via the Vested app. You can start investing in Mustang Bio Inc (MBIO) with a minimum investment of $1.
You can invest in shares of Mustang Bio Inc (MBIO) via Vested in three simple steps:
The 52-week high price of Mustang Bio Inc (MBIO) is $1.52. The 52-week low price of Mustang Bio Inc (MBIO) is $0.13.
The price-to-earnings (P/E) ratio of Mustang Bio Inc (MBIO) is
The price-to-book (P/B) ratio of Mustang Bio Inc (MBIO) is 31.75
The dividend yield of Mustang Bio Inc (MBIO) is 0.00%
The market capitalization of Mustang Bio Inc (MBIO) is $11.02M
The stock symbol (or ticker) of Mustang Bio Inc is MBIO